Dr. Reddy's Laboratories Ltd. Fundamental & Technical Research, Share Price Today

NSE : DRREDDY
NIFTY : Nifty 50
NIFTY SECTOR : Nifty Pharma

About Company

Dr. Reddy’s Laboratories Limited commenced its generics business in India in 1986 and is currently a trusted name in the healthcare industry consistently serving the needs of millions of patients with high quality, affordable and innovative medicines across therapy areas. The company is a leading India-based pharmaceutical company headquartered and having its registered office in Hyderabad, Telangana, India. Through its three businesses - Pharmaceutical Services and Active Ingredients, Global Generics and Proprietary Products - the Company offers a portfolio of products and services, including Active Pharmaceutical Ingredients (APIs), Custom Pharmaceutical Services (CPS), generics, biosimilars and differentiated formulations.

Market Cap. ₹ 107,770 Cr.

52 Week - High/Low ₹ 1,421/1,020

P/E Ratio 20.13

P/B Ratio 3.73

Enterprise Value ₹ 107,575 Cr.

ROE % 20.25

RSI Value 34.14

EMA 50 1267.82

EMA 200 1241.19

Market Cap. ₹ 107,770 Cr.

52 Week - High/Low ₹ 1,421/1,020

P/E Ratio 19.04

P/B Ratio 3.21

Enterprise Value ₹ 105,942 Cr.

ROE % 18.61

RSI Value 34.14

EMA 50 1267.82

EMA 200 1241.19

Add Parameters

Growth

Valuation

Calculators

Peer Comparison

Industry - Pharmaceuticals & Drugs

* Please refer to the Standalone data if Consolidated financial data for the company is not available.

Shareholding Pattern Numbers in percentages

Terms | Privacy | Contact Us